Wendt-Bristol Health Services Corp.; Order of Suspension of Trading, 57169 [E8-23086]

Download as PDF Federal Register / Vol. 73, No. 191 / Wednesday, October 1, 2008 / Notices c. Modernizing the Commission’s Disclosure System i. How should the Commission’s disclosure system be modernized? One possibility is a company file system. What alternative systems should be considered? What different or additional benefits might these alternatives provide? ii. How should a modern disclosure system, such as a company file system, be organized, and how could it improve the way disclosure information is submitted and used? iii. What features should any modernized disclosure system provide in order to serve the needs of filers, investors, regulators, and other users of information? Why? iv. Data tagging using XBRL, or eXtensible Business Reporting Language, is one way, but we understand there are other ways to structure data. What alternative ways could be used by companies to submit structured data to the Commission? v. What are the costs and benefits to investors and other market participants of structuring non-financial disclosures, including, for example, data tagging? vi. What time frame would be appropriate for implementing a company file system? vii. What benefits and costs to preparers and users of information would accompany the implementation of modernized disclosure system, such as a company file system, that requires all, or virtually all, data to be filed in a structured format? Would such a system be more useful to some investors, such as small or less sophisticated investors? Would some investors be harmed by such a system? Would larger companies benefit more than smaller companies? Would costs fall disproportionately on one group of companies? viii. Are any changes to the Commission’s disclosure regulations required for a transition to a company file system? How could these changes be identified? Dated: September 26, 2008. By the Commission. Florence E. Harmon, Acting Secretary. [FR Doc. E8–23105 Filed 9–30–08; 8:45 am] BILLING CODE 8011–01–P jlentini on PROD1PC65 with NOTICES 18:22 Sep 30, 2008 Jkt 214001 BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] Wendt-Bristol Health Services Corp.; Order of Suspension of Trading September 26, 2008. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of WendtBristol Health Services Corp. (‘‘WendtBristol’’) because it has not filed any periodic reports since the period ended March 31, 2000. Wendt-Bristol is quoted on the Pink Sheets operated by Pink OTC Markets, Inc. under the ticker symbol WMDB. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EDT on September 26, 2008, through 11:59 p.m. EDT on October 9, 2008. BILLING CODE 8011–01–P BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION SECURITIES AND EXCHANGE COMMISSION Sunshine Act Meeting [Release No. 34–58623; File No. SR–BATS– 2008–004] FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: [to be published]. Open meeting. PLACE: 100 F Street, NE., Washington, DC. STATUS: 10 a.m. Notice is hereby given, pursuant to the provisions of the Government in the Sunshine Act, Public Law 94–409, that Dated: September 26, 2008. Florence E. Harmon, Acting Secretary. [FR Doc. E8–23074 Filed 9–30–08; 8:45 am] By the Commission. J. Lynn Taylor, Assistant Secretary. [FR Doc. E8–23086 Filed 9–26–08; 4:15 pm] Cancellation of Meeting. The Open Meeting scheduled for Wednesday, October 1, 2008 has been cancelled. CHANGE IN THE MEETING: Sunshine Act Meeting For further information please contact the Office of the Secretary at (202) 551– 5400. Dated: September 26, 2008. Florence E. Harmon, Acting Secretary. [FR Doc. E8–23048 Filed 9–30–08; 8:45 am] DATE AND TIME OF PREVIOUSLY ANNOUNCED MEETING: Wednesday, October 1, 2008 at SECURITIES AND EXCHANGE COMMISSION VerDate Aug<31>2005 the Securities and Exchange Commission will hold a Closed Meeting on Thursday, October 2, 2008 at 2 p.m. Commissioners, Counsel to the Commissioners, the Secretary to the Commission, and recording secretaries will attend the Closed Meeting. Certain staff members who have an interest in the matters also may be present. The General Counsel of the Commission, or his designee, has certified that, in his opinion, one or more of the exemptions set forth in 5 U.S.C. 552b(c)(3), (5), (6), (7), 9(B) and (10) and 17 CFR 200.402(a)(3), (5), (6), (7), 9(ii) and (10), permit consideration of the scheduled matters at the Closed Meeting. Commissioner Casey, as duty officer, voted to consider the items listed for the Closed Meeting in closed session. The subject matter of the Closed Meeting scheduled for Thursday, October 2, 2008 will be: Formal orders of investigation; Institution and settlement of injunctive actions; Institution and settlement of administrative proceedings of an enforcement nature; A collection matter; Amicus consideration; An adjudicatory matter; and Other matters relating to enforcement proceedings. At times, changes in Commission priorities require alterations in the scheduling of meeting items. For further information and to ascertain what, if any, matters have been added, deleted or postponed, please contact: The Office of the Secretary at (202) 551–5400. 57169 PO 00000 Frm 00123 Fmt 4703 Sfmt 4703 Self-Regulatory Organizations; BATS Exchange, Inc.; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Consolidating Into a Single Rule Certain Requirements for Products Traded on the Exchange Pursuant to Unlisted Trading Privileges September 23, 2008. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 E:\FR\FM\01OCN1.SGM 01OCN1

Agencies

[Federal Register Volume 73, Number 191 (Wednesday, October 1, 2008)]
[Notices]
[Page 57169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-23086]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Wendt-Bristol Health Services Corp.; Order of Suspension of 
Trading

September 26, 2008.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Wendt-Bristol Health Services Corp. (``Wendt-Bristol'') because it has 
not filed any periodic reports since the period ended March 31, 2000. 
Wendt-Bristol is quoted on the Pink Sheets operated by Pink OTC 
Markets, Inc. under the ticker symbol WMDB.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed company is suspended for the period from 9:30 a.m. EDT on 
September 26, 2008, through 11:59 p.m. EDT on October 9, 2008.

    By the Commission.
J. Lynn Taylor,
Assistant Secretary.
[FR Doc. E8-23086 Filed 9-26-08; 4:15 pm]
BILLING CODE 8011-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.